353 results on '"Ingels, Alexandre"'
Search Results
2. Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review
3. Applicability of Bosniak 2019 for renal mass classification on portal venous phase at the era of spectral CT imaging using rapid kV-switching dual-energy CT
4. Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10)
5. Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group
6. 2023 WSES guidelines for the prevention, detection, and management of iatrogenic urinary tract injuries (IUTIs) during emergency digestive surgery
7. Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study)
8. Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective Study
9. Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review
10. Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma
11. Robotic Partial Nephrectomy
12. Open Radical Nephrectomy
13. Robotic Radical Nephrectomy
14. Decision-Making for Patients with Localized Renal Masses
15. Active Surveillance and Watchful Waiting in Renal Cancer
16. Management of Localized Renal Masses: The European Association of Urology (EAU), American Urological Association (AUA) and American Society of Clinical Oncology (ASCO) Guidelines’ Perspective
17. Ablative Therapies in Renal Cancer
18. Open Partial Nephrectomy: Current Status in the Minimally-Invasive Surgery Era
19. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries
20. Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
21. Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study
22. Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma
23. Current strategies to diagnose and manage positive surgical margins and local recurrence after partial nephrectomy
24. Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature
25. Robotic‐assisted native pyeloureterostomy with indocyanine green, after kidney transplantation
26. PD18-11 DELAYED PARTIAL NEPHRECTOMY FOLLOWING COMPLETE RESPONSE TO IMMUNOTHERAPY: FEASIBILITY AND RESULTS (UROCCR N°157)
27. Prostatectomie totale : jusqu’à quel âge ?
28. Ablative Therapies in Renal Cancer
29. Robotic Radical Nephrectomy
30. Open Partial Nephrectomy: Current Status in the Minimally-Invasive Surgery Era
31. Decision-Making for Patients with Localized Renal Masses
32. Management of Localized Renal Masses: The European Association of Urology (EAU), American Urological Association (AUA) and American Society of Clinical Oncology (ASCO) Guidelines’ Perspective
33. Robotic Partial Nephrectomy
34. Active Surveillance and Watchful Waiting in Renal Cancer
35. Open Radical Nephrectomy
36. Comorbidity and frailty assessment in renal cell carcinoma patients
37. Comparison of the iliac, vaginal and umbilical graft extraction in robot-assisted laparoscopic living donor nephrectomy
38. Postoperative outcomes of elderly patients undergoing partial nephrectomy
39. Glomerular Filtration Rate Measured Based on Iomeprol Clearance Assessed at CT Urography in Living Kidney Donor Candidates
40. BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model
41. The clinical role of the TME in solid cancer
42. Applicability of Bosniak 2019 for renal mass classification on portal venous phase at the era of spectral CT imaging using rapid kV-switching dual-energy CT
43. Retroperitoneal vs. transperitoneal robotic partial nephrectomy: a multicenter propensity-score matching analysis (PADORA Study - UroCCR n° 68)
44. Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives
45. Grade Group Underestimation in Prostate Biopsy: Predictive Factors and Outcomes in Candidates for Active Surveillance
46. Ultrasound Molecular Imaging of Renal Cell Carcinoma: VEGFR targeted therapy monitored with VEGFR1 and FSHR targeted microbubbles
47. IMMUNOSUPPRESSIVE OPTION WITH BELATACEPT IN HIV-POSITIVE KIDNEY TRANSPLANT RECIPIENTS
48. Future Uro-technologies: Hope or Hell for Prostate Cancer Patients?
49. Patient Selection for Focal Therapy for Prostate Cancer
50. Modified York Mason technique for repair of iatrogenic recto-urinary fistula: 20 years of the Montsouris experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.